Clinical trial
Comparison of Treatment with Acellular Fish Skin (AFS) to Acellular Human Cadaver Allograft (AHC) in the Treatment of Necrotizing Fasciitis (NF)
NCT06073301 is registered in ClinicalTrials.gov with Kerecis Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Treatment with Acellular Fish Skin (AFS) to Acellular Human Cadaver Allograft (AHC) in the Treatment of Necrotizing Fasciitis (NF)
- Lead sponsor
- Kerecis Ltd.
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- August 1, 2023
- Completion date
- December 1, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
necrotizing fasciitis